Evidence map›Paper›PMID 28229331›Full record

ArticleMolecular neurobiology2018

Involvement of Cellular Prion Protein in α-Synuclein Transport in Neurons.

Laura Urrea, Miriam Segura-Feliu, Masami Masuda-Suzukake, Arnau Hervera, Lucas Pedraz, José Manuel García Aznar, Miquel Vila, Josep Samitier, Eduard Torrents, Isidro Ferrer and 3 more

Erratum issuedOpen access · hybridAbstract read
In one paragraph

Article in Molecular neurobiology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 45 papers.

0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

45 citing papers in PubMed, 76 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Mechanisms of prion-induced toxicity.Cell and tissue research · 2023
    Review
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors at 7 institutions in 2 countries.

Laura UrreaMolecular and Cellular Neurobiotechnology, Institute of Bioengineering of Catalonia (IBEC), Parc Científic de Barcelona, Baldiri Reixac 15-21, E-08028, Barcelona, Spain.
Miriam Segura-FeliuMolecular and Cellular Neurobiotechnology, Institute of Bioengineering of Catalonia (IBEC), Parc Científic de Barcelona, Baldiri Reixac 15-21, E-08028, Barcelona, Spain.
Masami Masuda-SuzukakeDepartment of Dementia and Higher Brain Function, Tokyo Metropolitan Institute of Medical Science, Setagaya-ku, Tokyo, 156-8506, Japan.
Arnau HerveraMolecular and Cellular Neurobiotechnology, Institute of Bioengineering of Catalonia (IBEC), Parc Científic de Barcelona, Baldiri Reixac 15-21, E-08028, Barcelona, Spain.
Lucas PedrazBacterial infections: antimicrobial therapies. Institute of Bioengineering of Catalonia (IBEC), Parc Científic de Barcelona, Barcelona, Spain.
José Manuel García AznarMultiscale in Mechanical and Biological Engineering (M2BE), Aragon Institute of Engineering Research, Department of Mechanical Engineering, University of Zaragoza, Zaragoza, Spain.
Miquel VilaNeurodegenerative Diseases Research Group, Vall d'Hebron Research Institute-Center for Networked Biomedical Research on Neurodegenerative Diseases, Autonomous University of Barcelona, Barcelona, Spain.
Josep SamitierNanobioengineering Group, Institute for Bioengineering of Catalonia, (IBEC), Parc Científic de Barcelona, Barcelona, Spain.
Eduard TorrentsBacterial infections: antimicrobial therapies. Institute of Bioengineering of Catalonia (IBEC), Parc Científic de Barcelona, Barcelona, Spain.
Isidro FerrerInstitute of Neuroscience, University of Barcelona, Barcelona, Spain.
Rosalina GavínMolecular and Cellular Neurobiotechnology, Institute of Bioengineering of Catalonia (IBEC), Parc Científic de Barcelona, Baldiri Reixac 15-21, E-08028, Barcelona, Spain.
Masato HagesawaDepartment of Dementia and Higher Brain Function, Tokyo Metropolitan Institute of Medical Science, Setagaya-ku, Tokyo, 156-8506, Japan.
José Antonio Del RíoMolecular and Cellular Neurobiotechnology, Institute of Bioengineering of Catalonia (IBEC), Parc Científic de Barcelona, Baldiri Reixac 15-21, E-08028, Barcelona, Spain. jadelrio@ibecbarcelona.eu.
Biomedical Research Networking Center on Neurodegenerative Diseases · ESInstitute for Bioengineering of Catalonia · ESTokyo Metropolitan Institute of Medical Science · JPUniversitat de Barcelona · ESBellvitge University Hospital · ESInstitució Catalana de Recerca i Estudis Avançats · ESUniversidad de Zaragoza · ES

Funding

AGAUR 2015-FI-B-00817AGAUR SGR2014-1218Erciyes Üniversitesi (TR) ERC-2012-StG 306751Instituto de Salud Carlos III FIS PIE14/00034Instituto de Salud Carlos III PI10/01171Instituto de Salud Carlos III PI14/00757Instituto de Salud Carlos III PI2014/02-4Instituto de Salud Carlos III PRY-14-114MINECO AGL2015-71764-REDTMINECO BFU2015-67777-RMINECO BIO2015-63557-RMINECO DPI2015-64221-C2-1-RMINECO TEC2015-72718-EXPSeventh Framework Programme of the European Commission 228685-2Seventh Framework Programme of the European Commission 278486
6 · The paper itself

Abstract

The cellular prion protein, encoded by the gene Prnp, has been reported to be a receptor of β-amyloid. Their interaction is mandatory for neurotoxic effects of β-amyloid oligomers. In this study, we aimed to explore whether the cellular prion protein participates in the spreading of α-synuclein. Results demonstrate that Prnp expression is not mandatory for α-synuclein spreading. However, although the pathological spreading of α-synuclein can take place in the absence of Prnp, α-synuclein expanded faster in PrP

Indexed as

alpha-SynucleinAnimalsCells, CulturedHEK293 CellsHumansMaleMiceMice, 129 StrainMice, Inbred C57BLMice, TransgenicNeuronsPrion ProteinsProtein TransportPrPC Proteinsalpha-SynucleinPrion ProteinsPrPC ProteinsAmyloid spreadingMicrofluidic devicesPrnpSynuclein

Identifiers

PMID28229331
PMCPMC5840251
OpenAlexW2591352502

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.